跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

Why AI-Designed Drugs Haven't Changed Medicine Yet

1The Promise and the Puzzle2From Molecule to Medicine: The Journey a Drug Must Survive3Where AI Actually Helps in the Pipeline4The Prediction Gap: When a Good Molecule Meets a Real Body5The Long, Expensive Road of Clinical Trials6Money, Incentives, and the Business of Drug Development7Regulation, Evidence, and Trust8What Would Have to Change
From Molecule to Medicine: The Journey a Drug Must Survive

Three phases, three different questions

3 / 4
The three phases are not three attempts at the same question. They are three different questions asked in order. Phase I is about safety, in a small group, often healthy volunteers. Phase II is the first real test of whether the drug helps patients, in a few hundred people with the condition. Phase III is the confirmation step: thousands of patients, usually compared against the current standard treatment, to be sure the benefit is real and to catch harms too rare to appear earlier. Read the panels left to right and watch the size grow while the question gets stricter. Each panel is a gate, and a drug that fails one never reaches the next.
0:00 / 0:00

Once a candidate enters human testing, the trials are split into three phases, and each phase answers a different question. Phase I asks whether the drug is safe. Phase II asks whether it appears to work. Phase III asks whether it works better than what is already used, in a large enough group to be confident.

The phases also differ in size. Phase I involves a small number of participants, often healthy volunteers, and focuses on safety and how the body handles the drug. Phase II involves a few hundred patients with the condition and looks for an early signal of benefit. Phase III involves thousands of patients and usually compares the new drug against the current standard treatment, both to confirm benefit and to detect harms that are too rare to show up in smaller groups.

Each phase is a filter. A drug that fails Phase I never reaches Phase II, and a drug that fails Phase III has already consumed years of work and large sums of money. That is why the later a failure occurs, the more damaging it is.

上一页3 / 4下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion